This company listing is no longer active
Tecan Group Past Earnings Performance
Past criteria checks 2/6
Tecan Group has been growing earnings at an average annual rate of 15.4%, while the Life Sciences industry saw earnings growing at 26.1% annually. Revenues have been growing at an average rate of 16% per year. Tecan Group's return on equity is 8.9%, and it has net margins of 10.6%.
Key information
15.4%
Earnings growth rate
13.8%
EPS growth rate
| Life Sciences Industry Growth | 12.9% |
| Revenue growth rate | 16.0% |
| Return on equity | 8.9% |
| Net Margin | 10.6% |
| Next Earnings Update | 15 Aug 2023 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Tecan Group makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 22 | 1,144 | 121 | 214 | 78 |
| 30 Sep 22 | 1,110 | 113 | 212 | 79 |
| 30 Jun 22 | 1,077 | 105 | 210 | 79 |
| 31 Mar 22 | 1,012 | 113 | 201 | 76 |
| 31 Dec 21 | 947 | 122 | 192 | 72 |
| 30 Sep 21 | 911 | 136 | 192 | 70 |
| 30 Jun 21 | 875 | 150 | 191 | 68 |
| 31 Mar 21 | 803 | 127 | 182 | 65 |
| 31 Dec 20 | 731 | 104 | 172 | 62 |
| 30 Sep 20 | 691 | 94 | 160 | 59 |
| 30 Jun 20 | 651 | 84 | 149 | 56 |
| 31 Mar 20 | 644 | 79 | 149 | 58 |
| 31 Dec 19 | 637 | 73 | 149 | 60 |
| 30 Sep 19 | 627 | 70 | 150 | 59 |
| 30 Jun 19 | 616 | 67 | 151 | 59 |
| 31 Mar 19 | 605 | 69 | 146 | 55 |
| 31 Dec 18 | 594 | 71 | 141 | 51 |
| 30 Sep 18 | 582 | 70 | 139 | 50 |
| 30 Jun 18 | 570 | 69 | 138 | 49 |
| 31 Mar 18 | 559 | 67 | 137 | 50 |
| 31 Dec 17 | 549 | 66 | 136 | 50 |
| 30 Sep 17 | 536 | 62 | 132 | 49 |
| 30 Jun 17 | 523 | 57 | 129 | 48 |
| 31 Mar 17 | 515 | 56 | 127 | 47 |
| 31 Dec 16 | 506 | 55 | 125 | 47 |
| 30 Sep 16 | 491 | 55 | 123 | 45 |
| 30 Jun 16 | 476 | 55 | 120 | 43 |
| 31 Mar 16 | 458 | 56 | 115 | 41 |
| 31 Dec 15 | 440 | 57 | 110 | 40 |
| 30 Sep 15 | 434 | 52 | 108 | 41 |
| 30 Jun 15 | 427 | 48 | 106 | 42 |
| 31 Mar 15 | 413 | 44 | 104 | 41 |
| 31 Dec 14 | 400 | 40 | 103 | 39 |
| 30 Sep 14 | 389 | 44 | 99 | 40 |
| 30 Jun 14 | 378 | 48 | 95 | 41 |
| 31 Mar 14 | 383 | 47 | 93 | 43 |
| 31 Dec 13 | 388 | 46 | 92 | 45 |
| 30 Sep 13 | 389 | 43 | 93 | 48 |
| 30 Jun 13 | 391 | 41 | 94 | 50 |
| 31 Mar 13 | 391 | 42 | 95 | 51 |
| 31 Dec 12 | 391 | 42 | 96 | 51 |
| 30 Jun 12 | 377 | 39 | 93 | 46 |
Quality Earnings: TECN N has high quality earnings.
Growing Profit Margin: TECN N's current net profit margins (10.6%) are lower than last year (12.9%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: TECN N's earnings have grown by 15.4% per year over the past 5 years.
Accelerating Growth: TECN N's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: TECN N had negative earnings growth (-0.4%) over the past year, making it difficult to compare to the Life Sciences industry average (-1.5%).
Return on Equity
High ROE: TECN N's Return on Equity (8.9%) is considered low.